CD5 and Autoimmunity: The development of therapeutic strategies to downregulate CD5+ B cells so as to mitigate ongoing autoimmunity and protect high risk individuals could be achieved if it turns out that autoimmune repertoires are concentrated in CD5+ B cells, the latter being readily identified by flow cytometry.